Up a level |
Cappellini, M.D. and Elalfy, M. and El-Beshlawy, A. and Kattamis, A. and Chan, L.L. and Li, C. and Lin, K.H. and Quarta, G. and Sutcharitchan, P. and Taher, A. and Habr, D. and Roubert, B. and Porter, J. (2010) Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C. Haematologica-The Hematology Journal, 95 (2). pp. 718-719.